Protocol development, implementation, and research laboratory analysis relative to protocol 14-0100

Ended Awarded Last action

Contract number
HHSN27200006
Awardee
Awarding agency
Obligated
$2,094,753

Award facts

Opportunity
Contract value 100% obligated
$2,094,753.20 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Houston, TX 77030, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Vaccine treatment evaluation units (extension). The purpose of this modification is to deobligate remaining FY17 funds on line 3 task area D option 2 line 4… -$217,713
Funding Only Action P00008 · The purpose of this modification is to deobligate remaining FY17 funds on line 2 task area C option 1 and line 6 task area D option 5 and update various… -$104,911
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · The purpose of this modification is to extend the completion date of options 1 - 5 and update various articles and clauses $0
Funding Only Action 4 $43,457
Exercise an Option 3 $1,960,847
Other Administrative Action 2 · ; vaccine treatment evaluation units (extension) $0
Other Administrative Action 1 · ; vaccine treatment evaluation units $292,340
Original award $120,733

About this award

Written by GovTribe AI ·

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Baylor College of Medicine. The contract is for protocol development, implementation, and research laboratory analysis relative to Protocol 14-0100, with a period of performance through September 16, 2022 and a ceiling value of $2,094,753.20. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical trials of vaccines and treatments for infectious diseases. The contract has no set-aside designation. Baylor College of Medicine has subcontracted with Fundacao De Desenvolvimento DA Pesquisa (FUNDEP) in Brazil and George Washington University to support activities such as a planned Phase 1 clinical trial, immunological assays, and managing biological sample collection and processing. This contract aligns with NIAID's mission to conduct and support research to better understand, treat, and prevent infectious diseases.

Quick answers

Who was awarded contract HHSN27200006?

HHSN27200006 was awarded to Baylor College Of Medicine by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on November 30, 2015.

How much is contract HHSN27200006 worth?

The government has obligated $2,094,753 on HHSN27200006.

Is contract HHSN27200006 an order under another contract?

Yes. HHSN27200006 is a delivery order under HHSN272201300015I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200006 competed?

The extent of competition for HHSN27200006 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login